190 related articles for article (PubMed ID: 6859228)
1. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Huey R; Bloor CM; Kawahara MS; Hugli TE
Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
3. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
4. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
Hoffmann T; Böttger EC; Baum HP; Messner M; Hadding U; Bitter-Suermann D
Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
[TBL] [Abstract][Full Text] [Related]
6. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
7. Human C5a des Arg increases vascular permeability.
José PJ; Forrest MJ; Williams TJ
J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
[TBL] [Abstract][Full Text] [Related]
8. Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency.
Mathews KP; Curd JG; Hugli TE
J Clin Immunol; 1986 Jan; 6(1):87-91. PubMed ID: 3958137
[TBL] [Abstract][Full Text] [Related]
9. Synergism between inflammatory mediators in vivo. Induction of airway hyperresponsiveness to C3a in the guinea pig.
Watson JW; Drazen JM; Stimler-Gerard NP
Am Rev Respir Dis; 1988 Mar; 137(3):636-40. PubMed ID: 3278662
[TBL] [Abstract][Full Text] [Related]
10. C4a: the third anaphylatoxin of the human complement system.
Gorski JP; Hugli TE; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
[TBL] [Abstract][Full Text] [Related]
11. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
Grossklaus C; Damerau B; Lemgo E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
[TBL] [Abstract][Full Text] [Related]
12. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
14. Aggregate anaphylaxis and carboxypeptidase N.
Ryan JW; Berryer P; Hart MA; Ryan US
Adv Exp Med Biol; 1986; 198 Pt A():435-43. PubMed ID: 3028062
[TBL] [Abstract][Full Text] [Related]
15. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
Morgan EL; Weigle WO; Hugli TE
J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
[TBL] [Abstract][Full Text] [Related]
16. Effects of human anaphylatoxins on guinea pig atria.
Huey R; Bloor CM; Hugli TE
Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
[TBL] [Abstract][Full Text] [Related]
17. Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins.
Tan F; Jackman H; Skidgel RA; Zsigmond EK; Erdös EG
Anesthesiology; 1989 Feb; 70(2):267-75. PubMed ID: 2913861
[TBL] [Abstract][Full Text] [Related]
18. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
19. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
Meuer S; Becker S; Hadding U; Bitter-Suermann D
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
[TBL] [Abstract][Full Text] [Related]
20. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
